IDT has expanded its Coralville manufacturing footprint, boosting synthesis capacity by threefold, to meet the rapidly growing demand for MRD and NGS-based oncology research workflows

The upcoming Artemis II mission will send astronauts around the moon, but future missions will put humans back on the lunar surface, where they'll need a vehicle.

New entity strengthens SunHydrogen’s ties with Japan’s leading solar hydrogen research community and gives an ongoing scientific collaboration a permanent structure.

IDT has launched its first in vitro diagnostic NGS assays—Archer FUSION Plex™‑HT Dx and VARIANT Plex™‑HT Dx—marking its entry into the clinical diagnostics market with standardized, IVD‑grade solutions for oncology workflows.

Integrated DNA Technologies is launching a new suite of next-generation sequencing products designed to address persistent bottlenecks in cancer research workflows, the genomics company announced.

By joining forces, IDT will pair its nearly 40-year legacy of quality and service, as well as its global presence, with Ansa’s breakthrough enzymatic DNA synthesis platform to accelerate the delivery of challenging motifs, higher complexity, and longer constructs.

Riverain’s cardiothoracic AI suite is now available to sponsors with VIDA’s clinical trial imaging services, through the VIDA Intelligence PlatformTM